Peptides AcademyCJC-1295 + Ipamorelin Stack
The dual-pathway growth-hormone stack. CJC-1295 (GHRH analog) opens the pituitary somatotroph; Ipamorelin (GHSR agonist) amplifies the pulse. The combined effect is larger and more physiological than either alone.
Quick Comparison
| Property | peptide | The GH Stack: CJC-1295 + Ipamorelin |
|---|---|---|
| Source | Salmon DNA fragments | Various sources |
| Primary Mechanism | A2A receptor activation, DNA repair | Varies by ingredient |
| Key Benefits | Tissue regeneration, anti-inflammation, collagen boost | Multiple skin benefits |
| Best Time to Apply | AM or PM | AM or PM |
| Can Combine? | Generally compatible — check specific guidelines. | |
How to Use Together
Typical off-label protocols use daily subcutaneous injection of each peptide, most often pre-bed or in a fasted morning state to align with endogenous GH-pulse timing and avoid post-prandial insulin blunting. Courses run 8–12 weeks followed by a break. No-DAC CJC-1295 is strongly preferred over DAC for physiologic pulsatility.
Safety Notes
Elevated IGF-1 beyond the upper physiological range over extended periods carries theoretical cancer-promotion concerns and can produce GH-related adverse effects (fluid retention, arthralgia, insulin resistance). Baseline and periodic IGF-1 monitoring is standard in off-label practice.
